| HGNC Family | Non-coding RNAs |
| Name | hepatocellular carcinoma up-regulated EZH2-associated long non-coding RNA |
| Description | Biomarker of esophagus squamous cell carcinoma. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Long non‐coding RNA HEIH has emerged as an oncogenic regulator in multiple malignancies. In hepatitis B virus–related hepatocellular carcinoma, HEIH is highly expressed and its upregulation is associated with tumor recurrence, poor survival, and cell cycle dysregulation via binding to the polycomb repressor EZH2 to repress its target genes."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In colorectal cancer, HEIH promotes proliferation by binding to microRNAs (e.g., miR‐939) and thereby preventing their inhibition of key prosurvival factors such as NF‐κB–mediated Bcl‐xL expression."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " Similarly, in triple‐negative breast cancer HEIH is overexpressed and functions as a competing endogenous RNA (ceRNA), sequestering miR‐4458 to modulate the SOCS1 axis and influencing cell proliferation and apoptosis"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": ", with additional evidence in breast cancer underscoring its association with advanced malignancy."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": " In melanoma and other tumor models, HEIH appears consistently upregulated where it contributes to increased cell proliferation, migration, and invasion."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " In endometrial cancer, HEIH overexpression is linked to chemoresistance through activation of the MAPK pathway"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": ", and in cholangiocarcinoma it exerts oncogenic effects through a ceRNA network involving miR‐98‐5p and the upregulation of HECTD4."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " In esophageal squamous cell carcinoma, HEIH associates with EZH2 to repress TP53 expression, thereby contributing to a more aggressive phenotype"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": ", while in nasopharyngeal carcinoma HEIH functions as a molecular sponge for miR‐193a‐5p, leading to CDK8 upregulation and enhanced cellular progression."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": " In gastric cancer, elevated HEIH levels correlate with larger tumor size, metastatic features, and poor prognosis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Collectively, these studies indicate that HEIH is consistently upregulated across diverse cancer types, where it drives tumor progression through multiple mechanisms including (a) binding to chromatin modifiers like EZH2 to suppress tumor‐suppressor genes; (b) acting as a competing endogenous RNA to sequester tumor‐suppressive miRNAs; and (c) modulating key signaling pathways involved in proliferation, apoptosis, metastasis, and chemoresistance."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "3"}, {"type": "fg_fs", "start_ref": "5", "end_ref": "9"}, {"type": "fg_f", "ref": "4"}, {"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": "\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Fu Yang, Ling Zhang, Xi-song Huo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hepatology (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/hep.24563"}], "href": "https://doi.org/10.1002/hep.24563"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21769904"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21769904"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Chunhui Cui, Duanyang Zhai, Lianxu Cai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long Noncoding RNA HEIH Promotes Colorectal Cancer Tumorigenesis via Counteracting miR-939‒Mediated Transcriptional Repression of Bcl-xL."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res Treat (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4143/crt.2017.226"}], "href": "https://doi.org/10.4143/crt.2017.226"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29081216"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29081216"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Peng Li, Bo Zhou, Yuetao Lv, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA HEIH regulates cell proliferation and apoptosis through miR-4458/SOCS1 axis in triple-negative breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Cell (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13577-019-00273-1"}], "href": "https://doi.org/10.1007/s13577-019-00273-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31456112"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31456112"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Cheng Chen, Cheng Gu, Qian Ren, et al. "}, {"type": "b", "children": [{"type": "t", "text": "lncRNA HEIH, an indicator of high malignancy and poor prognosis, functions as an oncogene in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2020.11355"}], "href": "https://doi.org/10.3892/mmr.2020.11355"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32945377"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32945377"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Heba Nafea, Rana A Youness, Khaled Abou-Aisha, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA HEIH/miR-939-5p interplay modulates triple-negative breast cancer progression through NOS2-induced nitric oxide production."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.30234"}], "href": "https://doi.org/10.1002/jcp.30234"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33368266"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33368266"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Jun-Liang Guo, Tian Tang, Jin-Hong Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA HEIH Enhances Paclitaxel-Tolerance of Endometrial Cancer Cells via Activation of MAPK Signaling Pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathol Oncol Res (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12253-019-00718-w"}], "href": "https://doi.org/10.1007/s12253-019-00718-w"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31650338"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31650338"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Tao Wan, Hongguang Wang, Miaomiao Gou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA HEIH promotes cell proliferation, migration and invasion in cholangiocarcinoma by modulating miR-98-5p/HECTD4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2020.109916"}], "href": "https://doi.org/10.1016/j.biopha.2020.109916"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32062383"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32062383"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "XinYu Ding, Chen Qi, Jie Min, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA HEIH suppresses the expression of TP53 through enhancer of zeste homolog 2 in oesophageal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.15673"}], "href": "https://doi.org/10.1111/jcmm.15673"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32729661"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32729661"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Y-E Han, J-M Tao, S-X Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA HEIH modulates CDK8 expression by inhibiting miR-193a-5p to accelerate nasopharyngeal carcinoma progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_202101_24638"}], "href": "https://doi.org/10.26355/eurrev_202101_24638"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33577031"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33577031"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Y-J Yang, S Luo, L-S Wang "}, {"type": "b", "children": [{"type": "t", "text": "Effects of lncRNA-HEIH on proliferation, apoptosis and invasion of gastric cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_202009_23023"}], "href": "https://doi.org/10.26355/eurrev_202009_23023"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33015781"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33015781"}]}]}]}
|
| Synonyms | HCCAT2, LINC-HEIH, LNCRNA-HEIH, LINC00848 |
| NCBI Gene ID | 100859930 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
HEIH has 170 functional associations with biological entities spanning 2 categories (cell line, cell type or tissue, gene, protein or microRNA) extracted from 7 datasets.
Click the + buttons to view associations for HEIH from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of HEIH gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with HEIH gene from the CellMarker Gene-Cell Type Associations dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of HEIH gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of HEIH gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of HEIH gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of HEIH gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of HEIH gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |